Abiopharma

🔍 Riley Brian Joseph (Executive)

Company: Global Indemnity Group, LLC (GBLI)

Report Date: 2025-03-06

Detailed Transactions and Holdings:

• Acquired 11,384 shares of Book Value Rights (Derivative)
  Date: 2025-03-06 | Code: A | equity_swap_involved: false | shares_owned_after: 11,384.50 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 7,645 shares of Book Value Rights (Derivative)
  Date: 2026-03-05 | Code: A | equity_swap_involved: false | shares_owned_after: 7,645.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Book Value Rights ("BVRs") represent a contingent right to receive an amount of cash pursuant to the terms of the Notice of Book Value Rights Grant or Class A Common Shares of equal value as determined by the Issuer's board of directors. BVRs are awards indexed to Belmont Holdings GX, Inc.'s equity that may be settled in cash or Class A Common Shares.
• F2: Represents a grant of time-vested BVRs award in recognition of services rendered as an Officer of the Issuer. The BVRs vest as follows: (i) 33% on March 6, 2026, (ii) 33% on March 6, 2027, and (iii) 34% on March 6, 2028, in each case subject to the terms of the Notice of Book Value Rights Grant.
• F3: Represents a grant of time-vested BVRs award in recognition of services rendered as an Officer of the Issuer. The BVRs vest as follows: (i) 33% on March 5, 2027, (ii) 33% on March 5, 2028, and (iii) 34% on March 5, 2029, in each case subject to the terms of the Notice of Book Value Rights Grant.
• REMARKS: Exhibit 24 - Power of Attorney